EASL Studio

13 Dec at 18:00 CET

Hepatic encephalopathy: Underdiagnosed and underestimated

Next ERN webinar

12 Dec 2023, 17:00 CET

Alpha-1 antitrypsin deficiency: a poster child for nucleic acid therapy

EASL Policy Dialogues

Season 2 Episode 8 now available!

The political battle to reduce harms caused by alcohol

EASL Molecular Tumour Board

Now on demand!

Molecular Tumour Board in HCC: Is it possible and/or practical?

EASL Journal Club

Now on demand!

Inflamed and non-inflamed class of HCC: A revised immunogenomic classification

EASL LCS 2024

22-24 February 2024

Join the future of liver cancer care in Rotterdam (The Netherlands)

EASL SLD Summit 2023

Now on-demand!

For registered delegates only.

    Topics

    Basic Science

    846 Resources
    2 Languages
    View

    Cirrhosis & Complications

    1491 Resources
    5 Languages
    View

    General Hepatology

    2632 Resources
    4 Languages
    View

    Immune-Mediated and Cholestatic Diseases

    640 Resources
    3 Languages
    View

    Liver Tumours

    1924 Resources
    3 Languages
    View

    Metabolism, Alcohol & Toxicity

    2667 Resources
    6 Languages
    View

    Viral Hepatitis

    2150 Resources
    13 Languages
    View
      s5e13
      EASL Campus Connect
      Journal Club
      You may also be interested in

      Online Courses

      Discover the eLearning offering and obtain up to 40 CME credits!

      View

      EASL Molecular Tumour Board on intrahepatic cholangiocarcinoma

      This EASL-MTB was held on 23 May 2023 and discussed a clinical case of intrahepatic cholangiocarcinoma (CCA).

      View

      EASL Journal Club

      Look at all the Journal Clubs available so far and continue the discussion with the community!

      View

      Basic Techniques in Experimental Hepatology at a Glance

      Lean more about this educational offering illustrating scientific video protocols in the fields of hepatology and liver-related research. 

      View

        EASL Campus is supported by:

        • GSK

        • Boehringer Ingelheim

        GSK and Boehringer Ingelheim have had no input into the EASL content of EASL Campus.